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UM RESEARCH MAY LEAD 10-14-66
TO NEW LIEESAVER
Three million lives may be saved yearly as a result of tuberculosis research 
being conducted at the University of Montana.
The Department of Health, Education and Welfare has announced Dr. Carl L. Larson, 
UM professor of microbiology, has been awarded a conWAuing grant of $19*95^ for 
his 1967 studies seeking the development of a "killed1 vaccine for the prevention 
of tuberculosis.
The research is being conducted on a cooperative basis with Dr. Edgar Ribi 
of the Rocky Mountain Laboratory in Hamilton. It began the Hamilton lab in 1955 
when Dr. Larson was director of the facility.
Dr. Larson has been in charge of research at the Stella Duncan Memorial Institute 
on the UM campus for the past four years.
He explained rabbits, guinea pigs and mice are subjects in experiments to find 
a vaccine which will retain Its effectiveness in field conditions.
The live microbes, which are used in current vaccines, frequently die when removed 
from refrigeration for long periods and render the vaccine ineffective, he said. Dr. 
Larson also explained there is a possibility live vaccine could mutate into a virulant 
strain of tuberculosis.
Tuberculosis has been virtually eliminated in the United States during the past 
half century but 15 million new cases are reported worldwide yearly, largely in the 
under-developed nations. It is estimated three million deaths are attributed annually 
to the disease.
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